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Abstract
Background:  While chronic β-Hydroxy  β-Methylbutyrate (HMB) supplementation (≥ 2 wk)
lowers exercise induced muscle damage, its acute or timing effects have not been examined. The
purpose of this study was to investigate the acute and timing effects of oral HMB supplementation
on serum creatine kinase (CK), lactate dehydrogenase (LDH), muscle soreness, and maximal
voluntary contraction (MVC).
Methods: Sixteen non-resistance trained men (22 ± 2 yrs) were assigned to HMB-Pre or HMB-
Post groups. In a crossover design, all subjects performed 55 maximal eccentric knee extension/
flexion contractions on 2 occasions on either the right or left leg. HMB-Pre (N = 8) randomly
received 3 grams of either a placebo or HMB before and a placebo after exercise. HMB-Post (N =
8) received a placebo before and either 3 grams of HMB or a placebo after exercise. Muscle damage
tests were recorded before, at 8, 24, 48, and 72 hrs post exercise.
Results: There was a reduction in MVC and an increase in soreness in the quadriceps and
hamstrings following exercise (p  < 0.001). Although HMB-Pre approached significance in
attenuating soreness for the quadriceps (p = 0.07), there was no time × group effect. Serum indices
of damage increased, peaking at 48 hrs for CK (773%) (p < 0.001) and 72 hrs for LDH (180%) (p <
0.001). While there were no time × group effects of HMB on CK and LDH, post hoc analysis
revealed that only HMB-Pre showed no significant increase in LDH levels following exercise.
Conclusion: Our findings suggest no clear acute or timing effects of HMB supplementation.
However, consuming HMB before exercise appeared to prevent increases in LDH.
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Introduction
Oral administration of the leucine metabolite, beta-
hydroxy beta-methylbutyrate (HMB), has been associated
with increased lean body mass (LBM) [1,2], isometric [1],
isokinetic [1], and dynamic strength [3]. Moreover, these
positive effects of HMB supplementation have generalized
across young [4], elderly [5], untrained [1,3], trained
[6,7], and clinically cachexic conditions [8].
HMB is presently thought to at least partly exert its effects
via increasing the availability of substrate for de novo cho-
lesterol synthesis within skeletal muscle [3,9]. Specifi-
cally, HMB is converted to 3-hydroxy-3-methylglutaryl-
coenzyme A (HMG-CoA) with a subsequent increase in
the activity of the rate limiting enzyme for cholesterol syn-
thesis HMG-CoA reductase [3,9]. The result is an overall
reinforcement of the sarcolemma as well as the provision
of valuable substrate for its repair following muscle dam-
aging and or injurious exercise [3,9]. This is evidenced by
studies demonstrating that HMB leads to decreased mark-
ers of muscle damage following mechanically strenuous
exercise included lower levels of creatine kinase (CK)
[3,4], lactate dehydrogenase (LDH) [10], 3-methylhisti-
dine (3-MH) [3], urine urea nitrogen and plasma urea [2],
and muscular soreness [4].
The effectiveness and generalizability of HMB supplemen-
tation merits further research into how to optimize its
administration. Currently, the main variable examined
has been the optimal dosage of HMB supplementation
[1,3], which appears to be 3 grams per day [1,3]. However,
there are no studies that have examined the acute effects
of HMB administration (e.g its administration the day of
exercise), as studies thus far chronically load the supple-
ment (≥ 2 weeks) [3,6,11-13]. Moreover, if HMB does
exert acute effects, we are unaware of research investigat-
ing if there is an advantage to consuming the supplement
prior to as compared to after exercise (timing effects).
Based on findings demonstrating that the timing of inges-
tion appears to be an important element in recovery from
exercise for a number of nutrients and nutrient derivatives
[14-16], we feel this is a worthy question of interest.
Therefore, the purpose of this experiment was to investi-
gate the acute and timing effects of an HMB supplement
on indices of muscle damage and performance following
a unilateral eccentrically based muscle damaging protocol
in untrained subjects. For the reason that consuming
HMB prior to exercise is thought to allow its incorpora-
tion into muscle tissue before the strenuous event, and
because blood flow directed toward muscle tissue during
exercise would enhance this effect, we hypothesized that
consuming HMB prior to exercise would attenuate indices
of muscle damage relative to both a placebo, and con-
sumption of HMB after exercise.
Methods
Subjects
Sixteen healthy college-aged men (22 ± 2 yrs) were
recruited for the study. Subjects could not have partici-
pated in a resistance exercise program or taken nutritional
supplements for at least six months prior to data collec-
tion. Subjects also could not participate if they smoked,
had high resting blood pressure (≥ 140/90 mmHg) or
were currently taking anti-inflammatory agents. Screening
for the above criteria was obtained by phone or in person
prior to any testing. Each subject signed an informed con-
sent approved by the University Institutional Review
Board before participating in the study.
Experimental design
On the first visit subjects reported to the laboratory after a
12-hour fast. Body composition was measured using the
sum of 3 skinfolds (chest, abdomen, and thigh) following
the procedures of Jackson and Pollock [17]. Baseline mus-
cle soreness of the quadriceps and hamstrings was evalu-
ated using the visual analogue scale (VAS). Reliability
scores for the VAS have been reported as high at r = 0.97
for assessing soreness [18]. A baseline blood draw was
taken to measure serum CK and LDH levels. The first treat-
ment, either placebo (rice maltodextrin) or HMB supple-
ment was administered in 12 individual gelatin capsules
(3 grams) after the first 2 tests were completed. Following
ingestion of the capsules, the subjects sat in the laboratory
for 60 minutes. This duration was selected based on the
rationale that a 3 gram bolus of HMB appears to peak in
plasma 60 minutes after ingestion [19]. A second reason
was based on the premise that HMB may interact with
muscle in a similar manner to leucine [20]. After adminis-
tration of leucine containing essential amino acid mix-
ture, the rate of incorporation of labeled leucine into
mixed muscle protein rapidly rises after 30 minutes,
reaching peak values at 60 minutes before returning to
baseline at 120 minutes [21]. Therefore, it was reasoned
that a 60-minute interval would allow ample incorpora-
tion of HMB into skeletal muscle tissue. After the 60-
minute period the subjects underwent an isometric
strength test using a maximal voluntary contraction
(MVC) of the quadriceps and hamstrings [16], in which
reliability (test/retest) in our laboratory is reported high
when using a 1 week interval (r = 0.99, N = 8). Following
this test, the subjects performed an eccentric exercise bout.
Immediately after the completion of the exercise protocol,
the subjects ingested another 12 pills of either placebo or
HMB. All measurements used before the eccentric exercise
bouts were repeated at eight, 24, 48, and 72 hours after
the eccentric exercise bout.
Control of diet and exercise
All subjects were required to keep a record of their diet (all
food and beverages) for 48 hours prior to and during theNutrition & Metabolism 2009, 6:6 http://www.nutritionandmetabolism.com/content/6/1/6
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first experiment participated in. The dietary log was then
given to the subject with instructions to replicate the food
consumption for 48 hours prior to and during the second
randomly assigned experiment [22]. In addition, subjects
were told to refrain from taking any anti-inflammatory
dietary supplements or medications to prevent any further
nutritional or drug-related protection against the exercise-
induced muscle damage. These restrictions were enforced
48 hours before and during the testing period. Finally,
subjects were to keep activity to a minimum, and to not
perform any strenuous exercise 72 hours before and dur-
ing the testing period.
Supplementation and resistance exercise protocol
Subjects were randomly assigned to either pre (n = 8) or
post (n = 8) exercise HMB conditions. The MVC and mus-
cle damaging exercise protocol was adapted from White et
al. [16] in which all subjects performed 3 maximal iso-
metric contractions of the hamstrings and quadriceps fol-
lowed by 55 maximal eccentric unilateral knee extension/
flexion contractions on 2 separate occasions using the
Biodex™ (Shirley, New York) isokinetic machine, per-
formed on the dominant or non-dominant leg in a coun-
ter-balanced crossover design. HMB-Pre (n = 8) received 3
grams of HMB before and a placebo after exercise, or a pla-
cebo before and after exercise in the counter-balanced
crossover design separated by 2 weeks. HMB-Post (n = 8)
received a placebo before and 3 grams of HMB after exer-
cise, or a placebo before and after exercise in the counter-
balanced crossover design again 2 weeks later. For the
MVC protocol, the subject's upper and lower body was
restricted with shoulder and leg straps to help isolate the
exercising leg. Subjects completed ten sub-maximal con-
centric/concentric contractions of the quadriceps and
hamstrings of the dominant or nondominant leg for a
warm up. They were then tested for the MVC 3 minutes
after the completion of the warm up. All testing for MVC
was performed with the subject's knee joint placed at a
60° angle. Subjects alternated 5-second maximal isomet-
ric contractions separated by 30-second rest of the knee
extensors and flexors for a total of 3 repetitions per con-
traction. The highest values were then recorded. After 3
minutes of rest, the subjects performed the eccentric pro-
tocol which was divided into 1 set of 5 repetitions fol-
lowed by 5 sets of 10 repetitions. During the eccentric
protocol the Biodex™ was set through a range of motion
of 1.75 rad [100°], performed at an angular velocity of
1.05 rad/s [60°/s].
Creatine kinase and lactate dehydrogenase
Five mL of blood was taken from an antecubital vein using
sterile venipuncture techniques. Blood was collected in
EDTA coated tubes and centrifuged for 10 minutes at
3200 rpm. Samples were separated and stored at -80°C
until analysis. Serum CK and LDH activity were measured
in duplicate using an enzymatic assay kit (StanBio Labo-
ratories; Borne, Texas) after all samples had been col-
lected. Our coefficient of variation between duplicates was
less than 1%.
Statistical analysis
Sixteen subjects were selected as this number allowed us
to have 8 individuals placed in the HMB-Pre condition,
and 8 to be placed in the HMB-Post condition. Our
rationale for subject size was based on a study by Van
Someren et al. [23]. In a randomized cross over design
similar to our study, these investigators found that 2
weeks of HMB supplementation in 8 untrained subjects
was able to significantly decrease serum CK, soreness, and
the decline seen in MVC following an eccentric muscle
damaging protocol. Using the equation: effect size (ES) =
(experimental mean-control mean)/the pooled standard
deviation of peak serum CK levels (μl), the study by Van
Someren et al. had an ES of 1.4 = [(315-154)/116 μl].
Based on an alpha level of 0.05, a power of 80 and an
effect size of 1.4, a total of 14 subjects were needed for the
study.
A 3 × 5 [condition (HMB-Pre, HMB-Post, and placebo) ×
time (0, 8, 24, 48, and 72 hrs)] repeated Analyses of Vari-
ance (ANOVA) was used to test for significance between
MVC values and VAS scores. A 3 × 4 [condition × time (8,
24, 48, and 72 hrs)] repeated ANOVA was used to test for
significance for CK and LDH values which were normal-
ized to a percentage. A Tukey HSD post hoc test was used
to locate significance between time points if there was a
main effect of time. All significance was accepted at p ≤
0.05. All statistical procedures were carried out on Statis-
tica (StatSoft®, Tulsa, OK, USA).
Results
Subject characteristics
There were no differences between groups for age, body
weight, height, percent body fat or lean mass (Table 1). All
Table 1: Subject characteristics (N = 16)
Variables HMB-Pre (n = 8) HMB-Post (n = 8)
Age (yrs) 22 ± 2.0 22 ± 2.0
Height (cm) 177.0 ± 5.0 178 ± 4.0
Weight (kg) 72.0 ± 10.6 72.0 ± 9.0
Body Fat % 12.6 ± 6.0 13.2 ± 4.0
Values are means ± standard deviation.
* p < 0.05, significantly different from 0 time point
HMB pre exercise (HMB-pre), received supplement before exercise 
and placebo after; HMB post exercise (HMB-post), received 
supplement after exercise and placebo before exercise.Nutrition & Metabolism 2009, 6:6 http://www.nutritionandmetabolism.com/content/6/1/6
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subjects verbally confirmed that they had not been
involved in resistance exercise for at least six months and
were not taking any dietary supplements or anti-inflam-
matory agents prior to the study. Of the 16 subjects who
met screening criteria, none dropped out of the study, and
all completed the entire protocol as described.
Maximal Voluntary Contraction
Baseline MVC scores for both the quadriceps and ham-
strings were similar for all 3 conditions (Figure 1). There
was no condition by time interaction for MVC values for
either the quadriceps or hamstrings, however there were
significant time effects for MVC in both the quadriceps
(F(4,116) = 5.0, p ≤ 0.05, ES = 0.15) and hamstrings (F(4,116)
= 13.6, p ≤ 0.05, ES = 0.30). After the exercise bout, MVC
scores were significantly lower for all time points com-
pared to the pre-exercise values (Figure 1), with the great-
est declines occurring at 8 hrs in the quadriceps (-22%)
and at 48 hrs in hamstrings (-38%) with no acute or tim-
ing differences observed with HMB supplementation.
Muscle soreness
Pre-exercise values were not different among conditions
for muscle soreness (Figure 2). While the HMB-Pre condi-
tion approached significance in lowering quadriceps sore-
ness (p = 0.07) and visually appeared to decrease soreness
for hamstrings (Figure 2), there were no condition by time
interactions found. However, there were main time effects
for both the quadriceps (F(4,116) = 17, p ≤ 0.05, ES = 0.37)
and hamstrings (F(4,116) = 17, p ≤ 0.05, ES = 0.53) soreness.
After the exercise bout, soreness values were significantly
elevated for all time points compared to the pre-exercise
values (Figure 2, Table 1.0). Quadriceps soreness peaked
at 24 h for HMB-Pre (2.0 cm), and at 48 h for both HMB-
Post (2.6 cm) and placebo (2.8 cm) conditions (Figure 2),
while hamstring soreness peaked at 48 h for HMB-Pre (3.4
cm), HMB-Post (4.4 cm), and placebo (4.2 cm) condi-
tions (Figure 2).
Changes in serum CK and LDH
There were no differences in serum CK values among the
3 conditions at baseline. While visually HMB-Pre
appeared to decrease the rise in serum CK following exer-
cise (Figure 3), there was no condition by time interaction
after the exercise bout. However, there was a significant
time effect (F(3,87) = 6.6, p ≤ 0.05, ES = 0.20). A significant
percent increase in CK was found for all 3 groups peaking
at 48 hrs for both placebo (906%)(p < 0.001) and HMB-
Post (1,000%)(p < 0.001) conditions, and at 72 hrs (508
%) for the HMB-Pre condition. The supplement or timing
of ingestion had no significant effect on serum CK at any
time points. There were no differences in LDH values
among the 3 conditions at baseline. While there was a sig-
nificant time effect for % increase in serum LDH (F(3,87) =
14.1, p ≤ 0.05, ES = 0.33) (Figure 3), there was no time ×
group interaction. Post hoc analysis revealed that LDH
values significantly increased in both the placebo (219%,
72 hrs) and HMB-Post (247%, 72 hr) groups (Table 2).
However, there were no significant increases in LDH val-
ues in the HMB-Pre condition (Table 2, Figure 3).
Discussion
This study was designed to determine if HMB taken in
close proximity to exercise (acute effects) could lower
Peak torque of maximal voluntary contraction (MVC) for the knee extensors and flexors across the 72 hours Figure 1
Peak torque of maximal voluntary contraction (MVC) for the knee extensors and flexors across the 72 hours. 
Values are means ± standard errors, * p ≤ 0.05, significantly different from 0 time point, there were no differences among con-
ditions. HMB-Pre, received HMB before exercise and placebo after; HMB-Post, received HMB after exercise and placebo 
before exercise; Control, received a placebo before and after exercise; N, newtons.Nutrition & Metabolism 2009, 6:6 http://www.nutritionandmetabolism.com/content/6/1/6
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indirect markers of muscle damage, and whether these
acute effects were greater when the supplement was
administered before as compared to after exercise (timing
effects). Muscle damage was chemically inferred through
plasma CK and LDH levels, functionally through isomet-
ric MVC of the quadriceps and hamstrings, and muscle
soreness through the use of a VAS. Our study found that
there were no clear differences in indirect markers of mus-
cle damage regardless of the time of ingestion; however,
we did notice that consuming HMB prior to exercise was
able to prevent LDH values from significantly increasing
following muscle damaging exercise.
We also noted that consuming HMB prior to exercise vis-
ually attenuated the rise in CK (Figure 3), and soreness in
both the quadriceps (p = 0.07), and hamstrings (Figure 2).
Intriguingly, the placebo and HMB-Post conditions expe-
rienced virtually identical changes in each of these param-
eters. In a similar cross over design study, Van Someren et
al. [4] found that 2 weeks of HMB supplementation prior
Visual analogue soreness across the 72 hours for the quadriceps and hamstrings Figure 2
Visual analogue soreness across the 72 hours for the quadriceps and hamstrings. Values are means ± standard 
errors. * p ≤ 0.05, significantly different from 0 time point, there were no differences among conditions. HMB-Pre, received 
HMB before exercise and placebo after; HMB-Post, received HMB after exercise and placebo before exercise; Control, 
received placebo before and after exercise.
Percent change in serum creatine kinase (CK) and lactate dehydrogenase (LDH) values across the 72 hours Figure 3
Percent change in serum creatine kinase (CK) and lactate dehydrogenase (LDH) values across the 72 hours. 
Values are means ± standard errors. * p ≤ 0.05, significantly different from 0 time point, there were no differences among con-
ditions. HMB-Pre, received HMB before exercise and placebo after; HMB-Post, received HMB after exercise and placebo 
before exercise; Control, received placebo before and after exercise.Nutrition & Metabolism 2009, 6:6 http://www.nutritionandmetabolism.com/content/6/1/6
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to muscle damaging exercise was able to significantly
lower both serum markers of muscle damage and muscle
soreness. Serum markers of muscle damage are known to
be notoriously variable [16,24,25] and perhaps in order
to have enough power to see significant effects of consum-
ing HMB prior to exercise relative to the placebo and
HMB-Post groups it may need to be loaded (≥ 2 weeks)
prior to the exercise bout such as was done in the study by
Van Someren et al. [4].
All of the studies that we are aware of have administered
HMB for at least 2 weeks prior to the muscle damaging
bout [3,6,11-13]. Presently, we are unaware of what the
length of time needed for loading HMB would be in order
to see significant effects. Exposure of isolated non muscle
tissues to acid has revealed HMB concentrations as high as
100 μM [26]. If HMB is covalently bound to muscle tissue,
it is conceivable that consuming the supplement increases
these concentrations over time. With other amino acid
Table 2: Values for CK, MVC, and VAS for the three supplement groups
Variables 0 8 hrs 24 hrs 48 hrs 72 hrs
MVC Knee Extensors Control 216 ± 10 178 ± 29* 193 ± 17 191 ± 16 180 ± 22*
(N) Pre 224 ± 15 170 ± 28* 188 ± 17 206 ± 16 165 ± 22*
Post 231 ± 15 171 ± 28* 210 ± 16 208 ± 15 215 ± 23
MVC Knee Flexors Control 118 ± 7 92 ± 11 82 ± 6 80 ± 8 76 ± 8
(N) Pre 127 ± 10 92 ± 16 91 ± 9 97 ± 11 79 ± 12*
Post 127 ± 12 88 ± 13 92 ± 11* 71 ± 12* 85 ± 14*
VAS Quadriceps Control 0.0 ± 0.0 2.0 ± 0.4 2 ± 0.4 2.6 ± 1.4* 1.0 ± 0.4
(cm) Pre 0.0 ± 0.0 0.7 ± 0.5 1.9 ± 1.0* 1.5 ± 1.0 0.9 ± 1.0
Post 0.0 ± 0.0 1.0 ± 0.3 2.0 ± 1.0 3.0 ± 1.0* 2.6 ± 1.0*
VAS Hamstrings Control 0.0 ± 0.0 1.1 ± 0.3 2.1 ± 0.5 4.2 ± 0.6* 2.4 ± 0.5*
(cm) Pre 0.0 ± 0.0 0.7 ± 0.7 2.3 ± 0.7 3.4 ± 0.8* 2.4 ± 0.7
Post 0.0 ± 0.0 1.2 ± 0.5 2.2 ± 0.7 4.4 ± 0.9* 4.1 ± 0.8*
CK Control 165 ± 36 398 ± 95 623 ± 140 1032 ± 141* 801 ± 204
(U/L) Pre 201 ± 51 382 ± 135 551 ± 135 853 ± 396 1098 ± 289*
Post 199 ± 51 430 ± 134 759 ± 199 1531 ± 937* 937 ± 289*
LDH Control 113 ± 7 125 ± 10 131 ± 18 186 ± 29 372 ± 78*
(U/L) Pre 144 ± 10 154 ± 23 134 ± 25 159 ± 41 224 ± 110
Post 124 ± 10 129 ± 22 129 ± 26 219 ± 41 419 ± 111*
Values are means ± standard deviation.
* p < 0.05, significantly different from 0 time point
Pre, received supplement before exercise and placebo after; Post, received supplement after exercise and placebo before exercise; Control, 
received placebo before and after exercise; CK, creatine kinase; MVC, maximal voluntary contraction; N, newtons; VAS, visual analogue scale.Nutrition & Metabolism 2009, 6:6 http://www.nutritionandmetabolism.com/content/6/1/6
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derivatives such as creatine monohydrate, loading when
administering large bolus ingestions (20 grams per day)
can saturate muscle tissue within 1 week's time, while sup-
plementing with lower doses (3 grams) takes longer to sat-
urate muscle (28 days) [27]. If a period of loading is
necessary, then it may explain the dose response seen in
past studies. For example, Nissen et al.[3] found that con-
suming HMB at 3 grams per day while resistance training
3 days per week over 32 weeks time resulted in greater
changes in total body strength and lean body mass than
1.5 grams. While this is only speculative, it may be that 3
grams resulted in greater saturation of muscle tissue with
HMB than the 1.5 gram condition.
One limitation in our study would be that we analyzed
indirect indices of muscle damage. However, there are a
number of direct measures including z-line streaming, zig-
zagging, and centralized nuclei which may give valuable
information as to the effects of HMB on indices of muscle
damage.
In conclusion, our findings suggest that there were no
clear acute or timing effects of HMB supplementation on
indirect markers of muscle damage. However, consuming
HMB an hour before exercise appeared to prevent
increases in select markers of damage. It appears that HMB
may need a loading period prior to exercise in order to sig-
nificantly attenuate the rise in indices of muscle damage
relative to placebo and HMB-Post conditions. Similar to
creatine based studies, we suggest that future researchers
examine how loading effects the concentration of HMB
into skeletal muscle tissue, and what variables including
duration of the loading period, and dosage loaded play in
saturating skeletal muscle.
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